Search results for FOXO3A antibody

Anti-FOXO3A antibody [1E2], Abcam, AB314007

What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-FOXO3A antibody [EPR1950], Abcam, AB109629

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-FOXO3A antibody [HL2190], Abcam, AB317158

Anti-FOXO3A antibody [RP23040119], Abcam, AB313442

What are recombinant multiclonals? Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including: - The sensitivity of polyclonal antibodies by recognising multiple epitopes - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production View our range of recombinant multiclonal antibodies .

FOXO3A antibody [C3], C-term, Genetex, GTX100277

FOXO3A Antibody (YA428)(PBS only), MedChemexpress, HY-P80677A

FOXO3A Antibody (YA428) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to FOXO3A.

Anti-FOXO3A antibody [EPR29854-587], Abcam, AB323467

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Forkhead Box Protein O3 (FOXO3A) Antibody, Abbexa, abx233202

FOXO3A Antibody is a Rabbit Polyclonal against FOXO3A.

Forkhead Box Protein O3 (FOXO3A) Antibody, Abbexa, abx430684

FOXO3A Antibody is a Goat Polyclonal antibody against FOXO3A.

Forkhead Box Protein O3 (FOXO3A) Antibody, Abbexa, abx011937

Forkhead Box Protein O3 (FOXO3A) Antibody is a Rabbit Polyclonal antibody for the detection of FOXO3A. Forkhead box O-class (FOXO) transcription factors are mammalian homologue of DAF-16, a known lifespan regulator of Caenorhabditis elegans. FOXO transcription factors, such as FOXO1, FOXO3a, and FOXO4, have been linked to the regulation of cell cycle, apoptosis, DNA repair, oxidative stress, and metabolism. FOXO proteins are proposed to be dual regulated by Akt-mediated phosphorylation and Skp2-mediated ubiquitination, which are usually initiated by growth factors and cytokines. FOXO proteins are also activated by stress, which induces gene expression that contributes to cell cycle arrest, implicating FOXO proteins as tumor suppressors. Specifically, FOXO3a (FKHR-L1) is a transcriptional activator for apoptosis in the absence of survival factors, such as in neural cell death triggered by oxidative stress. In the presence of survival factors like IGF-1, AKT1/PKB phosphorylates on Thr-32 and Ser-253. FOXO3a is inactivated when phosphorylated by AKT1 on Thr-32 and Ser-253.